Waypoint Bio
Organization · Startup · 1 item since Jun 2026
Deals & regulation
- Jun 2
Raised $20M · led by Amplify Partners
Items
- Jun 2
Waypoint Bio raises $20M for AI-designed CAR T
The Series A advances a spatial-biology and AI platform for designing CAR T cell therapies for solid tumors, funding its WAY-103 program toward an investigator-initiated trial.